Oh Hyoung Min, Yoon Yoo-Seok, Han Ho-Seong, Kim Ji Hoon, Cho Jai Young, Hwang Dae-Wook
Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Korean J Hepatobiliary Pancreat Surg. 2012 Nov;16(4):167-71. doi: 10.14701/kjhbps.2012.16.4.167. Epub 2012 Nov 30.
BACKGROUNDS/AIMS: Postoperative diabetes mellitus (DM) after pancreaticoduodenectomy (PD) may compromise the long-term quality of life in survivors after the operative procedure due to the treatment difficulty and its related complications. The aim of this study is to determine the incidence of new-onset pancreatogenic DM after PD and investigate the risk factors for this complication.
Among 170 patients who had undergone PD between November 2003 and September 2009, 98 patients were selected for this study. The selected patients were non-diabetic prior to the operation and had undergone follow-up tests for glucose metabolism and an abdominal computed tomography (CT) scan 1 year after the operation. The clinical data of these patients were retrospectively analyzed by reviewing the medical records, radiologic images, and pathologic reports.
Postoperative pathology confirmed malignant tumors in 91 patients, borderline malignancy in 5, and benign tumor in 2. The tumor locations included the pancreatic head (n=30), the common bile duct (CBD) (n=30), ampulla of Vater (n=30), and the duodenum (n=8). New-onset DM occurred in 17 (17.4%) of the 98 patients during the first year after the operation. The comparative analysis between postoperative DM (+) and DM (-) groups revealed that the atrophy of the remaining pancreas was the only significant risk factor for development of postoperative DM after PD.
This study suggests that the atrophy of the remaining pancreas increases the risk of pancreatogenic DM after PD, and efforts to prevent pancreatic atrophy are needed to decrease this complication.
背景/目的:胰十二指肠切除术(PD)后发生的术后糖尿病(DM),由于治疗困难及其相关并发症,可能会影响手术幸存者的长期生活质量。本研究的目的是确定PD后新发胰腺源性DM的发生率,并调查该并发症的危险因素。
在2003年11月至2009年9月期间接受PD的170例患者中,选取98例患者进行本研究。所选患者术前无糖尿病,术后1年进行了葡萄糖代谢随访检查和腹部计算机断层扫描(CT)。通过查阅病历、影像学图像和病理报告,对这些患者的临床资料进行回顾性分析。
术后病理确诊恶性肿瘤91例,交界性恶性肿瘤5例,良性肿瘤2例。肿瘤部位包括胰头(n = 30)、胆总管(CBD)(n = 30)、Vater壶腹(n = 30)和十二指肠(n = 8)。98例患者中有17例(17.4%)在术后第一年发生新发DM。术后DM(+)组和DM(-)组的比较分析显示,残余胰腺萎缩是PD后发生术后DM的唯一显著危险因素。
本研究表明,残余胰腺萎缩增加了PD后胰腺源性DM的风险,需要努力预防胰腺萎缩以减少该并发症。